(Q34708196)

4 August 2017

title

Eaton-Lambert myasthenic syndrome: long-term treatment of three patients with prednisone (English)

1 reference

4 August 2017

Eaton-lambert myasthenic syndrome: Long-term treatment of three patients with prednisone (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

13 September 2023

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

13 September 2023

author name string

E. W. Streib

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6272625

13 September 2023

A. D. Rothner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6272625

13 September 2023

language of work or name

1 reference

1 November 1981

1 reference

full work available at URL

4 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410100507

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410100507

13 September 2023

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

13 September 2023

1 reference

4 August 2017

volume

10

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

448-453

1 reference

Guanidine and germine in Eaton-Lambert syndrome

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Unusual myasthenic state in a teen-age boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Clinical Syndromes of Myasthenia in Infancy and Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Antimyasthenic Action of Corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

A neuromuscular transmission block produced by a cancer tissue extract derived from a patient with the myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Guanidine and neuromuscular transmission. I. Effect on transmitter release occurring spontaneously and in response to single nerve stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Guanidine and neuromuscular transmission. II. Effect on transmitter release in response to repetitive nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Hyperthyroidism and myasthenia gravis with features of Eaton-Lambert syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Cholinergic dysautonomia and Eaton-Lambert syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

Myasthenic syndromes in hypothyroidism. Electrophysiological study of neuromuscular transmission and muscle contraction in two patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410100507

ACTH and neuromuscular transmission: Electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Guanidine treatment and impaired renal function in the Eaton-Lambert syndrome

13 September 2023

2

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma

13 September 2023

3

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Bulletin of the Los Angeles neurological societies

13 September 2023

4

33

9

Brown

1968

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Eaton-Lambert Syndrome in a 9-Year-Old Girl

13 September 2023

6

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release

13 September 2023

12

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Myasthenia gravis: a new hypothesis of the pathogenesis and a new form of treatment

13 September 2023

13

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

The Eaton-Lambert syndrome and autoimmune disorders

13 September 2023

15

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Glucocorticoid enhancement of guanidine neuromuscular facilitation

13 September 2023

16

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Quantal components of end-plate potentials in the myasthenic syndrome

13 September 2023

23

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome

13 September 2023

28

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Acta Neurologica Scandinavica

13 September 2023

30

57

350

Nilsson

1978

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Prednisone-neostigmine interactions at cholinergic junctions

13 September 2023

31

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Neuromuscular Transmission in Thyroid Disease

13 September 2023

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Glucocorticoids and Mammalian Motor Nerve Excitability

13 September 2023

35

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.

13 September 2023

37

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Reversible Hepatic Dysfunction Owing to Guanidine Treatment

13 September 2023

39

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

Corticosteroids: a direct effect at the neuromuscular junction

13 September 2023

43

1 reference

https://api.crossref.org/works/10.1002/ANA.410100507

13 September 2023

Identifiers

1 reference

4 August 2017

1 reference